Current Report Filing (8-k)
July 26 2022 - 10:46AM
Edgar (US Regulatory)
0001413488
false
0001413488
2022-07-21
2022-07-21
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
Date of Report (Date of earliest event
reported): July 21, 2022
CANNABIS GLOBAL, INC.
(Name of registrant in its charter)
Nevada |
|
333-146404 |
|
99-0539775 |
(State or jurisdiction of |
|
(Commission File |
|
(IRS Employer |
incorporation or organization) |
|
Number) |
|
Identification No.) |
520 S. Grand Avenue, Suite 320, Los Angeles, CA 90071
(Address of principal executive offices)
(310) 986-4929
(Registrant’s telephone number)
N/A
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instructions
A.2 below):
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
Trading Symbols |
Name of Exchange on Which Registered |
Common |
CBGL |
None |
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 21, 2022, the Registrant's Director, Principal
Executive Officer and Principal Accounting and Financial Officer, Arman Tabatabaei, resigned his positions. Mr. Tabatabaei's resignations
were not the result of any disagreements with the Company, known to an executive officer of the Registrant, as defined in 17 CFR 240.3b-7,
on any matter relating to the registrant’s operations, policies, or practices. Mr. Tabatabaei will continue to work with the Company
as a non-executive consultant from August 1, 2022, to August 31, 2022, with an option for continued services in the month of September
2022.
Effective July 21, 2022, the Registrant named Edward
Manolos as Principal Executive Officer and Principal Accounting and Financial Officer. There were no arrangements or understandings between
Mr. Manolos and any other person pursuant to which he was named as Principal Executive Officer and Principal Accounting and Financial
Officers. There are no family relationships between Mr. Manolos and any other director or executive officer of the Company. Mr. Manolos
has served on the board of directors since May 25, 2019. There have been no transactions between Mr. Manolos and the Company since the
beginning of the last fiscal year, and none are currently proposed, that would require disclosure under Item 404(a) of Regulation S-K.
The registrant and Mr. Manolos entered a contract providing for a monthly salary of $5,000 payable in cash or an equivalent number of
common shares.
Mr. Manolos is one of the founders and Directors
of Cannabis Global, Inc. and is an accomplished pioneer in California’s Medical Marijuana industry. In 2004, he opened the very
first Medical Marijuana Dispensary in Los Angeles County under the name CMCA. He has managed and operated over thirty-five dispensaries
from Los Angeles to San Jose including twenty in Los Angeles Pre-ICO/Proposition D. He is also credited with starting Los Angeles’
first Medical Marijuana farmers market referred to as “The California Heritage Farmer’s Market,” which attracted local
and international media attention and was the first of its kind. He is currently a member of the board of directors of Marijuana Company
of America (OTCQB: MCOA). In 2016, Mr. Manolos was appointed to the advisory board of Marijuana Company of America and Cannabis Strategic
Ventures (OTCQB: NUGS) and was tasked with identifying and structuring strategic partnerships and driving product development.
Item 9.01 Financial Statements and Exhibits
Exhibit No. |
Document |
|
17.1 |
Letter from Arman Tabatabaei |
Filed Herewith |
|
|
|
104 |
Cover Page Interactive Data File - the cover page XBRL tags are embedded with the Inline XBRL document. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CANNABIS GLOBAL, INC. |
|
|
|
Date: July 26, 2022 |
By: |
/s/ Edward Manolos |
|
|
Edward Manolos
(Principal Executive Officer)
|
Cannabis Global (PK) (USOTC:CBGL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Cannabis Global (PK) (USOTC:CBGL)
Historical Stock Chart
From Dec 2023 to Dec 2024